Tamoxifen is unproved for gynaecomastia [8]

British Medical Journal

Volumn 327, Issue 7422, 2003, Pages 1050-

  Doughty, Julie C ^a   Wilson, Christopher R ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADOLESCENT; DRUG APPROVAL; DRUG INDICATION; DRUG SAFETY; GYNECOMASTIA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; ESTROGEN ANTAGONISTS; GYNECOMASTIA; HUMANS; MALE; TAMOXIFEN;

EID: 0242383438     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Khan HN, Blamey RW. Endocrine treatment of physiological gynaecomastia. BMJ 2003;327:301-2. (9 August.)
2. Nydick M, Bustos J, Dale J H, Rawson RW. Gynaecomastia in adolescent boys. JAMA 1961;178:449-557.